- Home
- ORIQ vs COEP Comparison
ORIQ vs COEP Comparison
Compare ORIQ & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$15.50
Company Overview
Basic Information| Metric | ORIQ | COEP |
|---|---|---|
| Founded | 2024 | 2017 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.6M | 100.4M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORIQ | COEP |
|---|---|---|
| Price | $10.16 | $15.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.1K | ★ 73.1K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $500,996.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.98 | $2.31 |
| 52 Week High | $10.20 | $21.41 |
Technical Indicators
Market Signals| Indicator | ORIQ | COEP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 47.42 |
| Support Level | N/A | $15.40 |
| Resistance Level | N/A | $16.80 |
| Average True Range (ATR) | 0.00 | 1.43 |
| MACD | 0.00 | -0.20 |
| Stochastic Oscillator | 0.00 | 7.42 |
Price Performance
Historical Comparison ORIQ
COEP
About ORIQ Origin Investment Corp I Ordinary Shares
Origin Investment Corp I is a blank check company.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.